Member Info for PM2022

I share the frustration. I think Suzy is great but it's an issue with negotiations and how they are done. Need to stick to timelines when negotiating and follow up and really push for it. The Cenkos deal was also a joke. I thought the purpose of them getting all those shares was to bring in institutional investors to buy into the open market not into a placing. Been almost a year?

Ripley94,

We are so close to news now that it is highly unlikely Val will go down to the low 20s again and no delays this time. I think we would have heard if they had any funding issues and trial set up work has continued throughout. Suzy is very confident. The deal almost definitely should come soon. I am going for news on Thursdays or next week but not after May imo.

When looking at potential short term upside anywhere between 50-100p then I think you have made a mistake selling some at 28p as the market cap is very cheap.

Top of the riser list at the close of play. We should attract more attention. Should be a nice rise over the next few days going into company changing news.

Likely news due in the coming weeks:

1) 201 funding news. Company making news. Imminent any day.
2) 201 trial details including number of hospitals, trial number etc.
3) Triple X breast cancer news in June.
4) BC201 finding to be published shortly.
5) End of year financials.

Market cap only 18 million. Can hit 50 million in the next few weeks.

End of year results are yet to be published and I think this will come once funding is confirmed. BC201 news was imminent and 401 has been going on for a while. Triple breast cancer news also due in June. All can come one after the other.

We are hopefully looking at about 5/6 RNS in a short space of time. Also news regarding trials setups may well come soon after the funding news.

I have revised my short term target to 100p for the next 3 months for VAL> . A strong buy at this low market cap.

It's relative to the current share price and market cap. I am talking between 50p- 80p range after the deal. The overheads required for the current strategy is not that much. The lab will bring in income and so will money from the deal. Going commercial you would be looking at a few pounds. If you want £5 then fair enough but otherwise your comment is not valid.

It's ongoing so progress is continuous. If TRx had no intention of progressing they would have gone already. As no more delays it will either be 100% complete or probably mostly complete.

Positive tweet from Suzy. I remain very confident of a deal and not selling. If the deal gets done this stock will go wild so well worth a buy at this price imo.

200-300 plus % increase if funding comes through imo with further increases with trial set up news. These are the times to take a chance and invest with limited downside. If the deal failed we would have known already not after 2 delays. Surely they would have raised most of the cash if not all by now.

I still think the deal will happen in May. Risk to reward is amazing at this price.

Well I think she would make a better politician to be fair. I know how to negotiate and I would have taken it further than the current market cap that is for sure in two years. Still waiting for that 6 per cent given to Cenkos to come good.

I don't sell in frustration but the can keeps getting kicked about without anything ever being delivered.

The market cap is only 15 million so it's a great buy here. I have had enough of Suzy though. Not good enough as CEO. 2 Years and nothing at all and keeps missing targets and never over delivers. Maybe going from 15 to 20 p would be an achievement for her.

After all these delays I think Adam means that it would be the right thing to let us know first not some students. It's still a product owned by us so it would be the right thing to do.

I don't have much confidence with Suzy and Val regarding timelines. They need to get themselves sorted out. What happened to the journal with the BC201 findings? Not much has been done in the last 2 years to be fair and this deal has been nothing more than a joke so far.

Could get the sealed RNS deal on the same morning. Maybe they are now ready to move.

I have tried registering but no link was sent?

Suzy is on the panel “Dressing for Success Early as a BioPharma Start-up” at the LSX World conference (London) discussing the challenges facing growing companies.

I think it will be hard to talk without a deal. Deal perhaps by week one/two May. I don't see this going into June after two delays. It would be unbelievable if it did.

AIM is all about the timing of big news therefore Immu is not for me. It has a long way to go and they only just did the dosing. You might be sitting around for years with a drifting price before the trial results so I would prefer to stick with VAL.

Cancer drugs generate the largest revenue and have the greatest value and given our market cap is so low this has far greater upside in the next 1-2 years. Valirx all the way.

Poor attempt at a de-ramp Darth. Based on the comments in the RNS it looked they secured the funding for the entire pipeline here so it cannot be much longer. We can then compare the SP for both but regardless DDDD are burning about 1 million pounds a week so are due a huge placing for working capital and what will happen then.

Would rather stay here as far less risky with greater upside. For me the deal is 95% and we should get further news regarding trail set ups/ recruitments that would really change sentiment.

It's a strong upwards trend on the graphs here. That along with news due soon for the deal should mean this is a good bounce range to head to 45 p before the deal. Nice time to add.

I think we are expecting one very big RNS or two RNS one for funding and one for trail set up details including number of patients to be recruited and number of hospitals participating and that should see a huge rise.

Scancell given the large market cap and amount the market cap increased by is a great example of what to expect from a cancer set-up or recruitment starting RNS and we could be heading to 80-100 p with both RNS soon.

Just got another 20k shares. Like the drop to add a few more near my average but looking for it to move up now. It can only go so low and should turn soon with the deal to come soon.

Dynasty market cap probably exceed what we are valued. I am sure Derek is lining up the news and updates. Cheap entry point here and we know how fast Blue can move. Lets get to 0.6 today. Pendulum news will be huge take positions early.

This is a news rich period. Pendulum update in the next few weeks then people will understand the value and will be buying at 1p. Downside is very little given out portfolio and market cap. Pendulum valued at zero but likely worth 100s millions/billions.

Strong buy here this will grow massively.

The market cap is still only 20 million. Therefore 45 p before deal is fair price and 70-80 p after the deal.

We could reach Josh's target by the end of the day but I would not sell a single share at such a low market cap with a deal to come soon.

Big day today. 4 big reasons why we should see a decent rise to 40p soon before a deal and 65p plus after deal.

1) Q and A event. We know a deal is not far so this can only confirm what we know that a deal will come soon.
2) The new ISA allowance should see people increase positions.
3) THe charts are showing a higher low. Looks like we have reached the bottom of the range. We should bounce and break 35p easily soon.
4) We are significantly undervalued at this price. Risk to reward is excellent at this price.

Lots of people may want to get in at this price for trading reasons but what an excellent opportunity to invest for the wider Valirx shareholder base and increase positions. Would be good to see Suzy deliver a positive Q and A given two previous delays. GL all.